Clinical Trial

Speech-based AI-driven Diagnostics and Rehabilitation for Oral and Oropharyngeal Cancer.

Study acronym: speech omics
Completed
View on ClinicalTrials.gov →
Summary
Participants diagnosed with oral cancer, oropharyngeal cancer, or oral potentially malignant lesions, as well as healthy controls, had their speech audio recordings collected for the development and validation of AI-driven models for diagnosis and prognosis prediction of oral cancer and oropharyngeal cancer.
Trial Details
NCT Number NCT07347899
Lead Sponsor Yudong Xiao
Conditions Oral Cancer, Oropharyngeal Cancer
Enrollment 501 participants
Start Date 2017-07-17
Primary Completion 2022-04-30 (estimated)
Study Completion 2022-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-16